Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-84
SponsorSt. Joseph's Hospital and Medical Center, Phoenix

About this trial

To find out whether oral antibiotics given after transsphenoidal endoscopic surgery for pituitary adenoma improves sinus and nasal symptoms, reduces the incidence of infection (sinusitis), and helps mucosal healing in the nasal passages.

Eligibility criteria

Qualifiers

Adult patient undergoing endoscopic surgery for resection of pituitary tumors for nonfunctioning adenoma, acromegaly, or prolactinoma

Adults >18 and <85 years of age

English speaking and able to understand the ASK Nasal-12 and SNOT-22 scales

Free of any physical, mental, or medical condition which, in the opinion of the investigator, makes study participation inadvisable

Disqualifiers

Anaphylaxis/intolerance to the study drugs

Cirrhosis, hepatitis

Any solid organ transplant or bone marrow transplant. And any patient felt to be immunocompromised by the investigators

Renal failure on dialysis

Trial design

Treatments tested in this trial

  • Placebo
  • Oral Antibiotics cefdinir or trimethoprim/sulfamethoxazole

Treatment groups

116 Participants
are divided into 2 treatment groups

Sponsors and collaborators

St. Joseph's Hospital and Medical Center, Phoenix

Lead sponsor

Thomas Jefferson University

Collaborator

The Cleveland Clinic

Collaborator